Nurse Practitioner Program year 2022 Reported 2021–2022 Source: CMS Open Payments, 2026 publication

Ellen Scherrer

Nurse Practitioner, Adult Health Columbus, MS Nurse Practitioner

NPI 1609247139 CMS profile 10906860

4508 Highway 45 N, Columbus, MS 39705

Open in the dashboard

General payments

$892

56 records reported · program years 2021–2022

Research payments

$0

Paid to them · None reported · program years 2021–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Ellen Scherrer of Columbus, MS is reported in the CMS Open Payments database as having received $892 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $484 29
2021 General $408 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ellen Scherrer
  • Nurse Practitioner, Adult Health median
  • Middle half of Nurse Practitioner, Adult Health
  • National median

In program year 2025, general payments to Ellen Scherrer were reported at $0. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.

Show as a table
Year Ellen Scherrer Nurse Practitioner, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $408 $138 $43–$438 $132
2022 $484 $165 $54–$494 $149
2023 $0 $178 $61–$549 $160
2024 $0 $186 $62–$575 $164
2025 $0 $184 $59–$580 $169

Breakdown

Who paid General payments · program years 2021–2022
  1. AbbVie, Inc. $172 10 payments
  2. Novo Nordisk Inc $167 10 payments
  3. AstraZeneca Pharmaceuticals LP $103 7 payments
  4. Sanofi-Aventis U.S. LLC $87 6 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $87 5 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $82 5 payments
  7. Esperion Therapeutics, Inc. $57 4 payments
  8. Novartis Pharmaceuticals Corporation $46 3 payments
  9. GlaxoSmithKline, LLC. $30 2 payments
  10. Boston Scientific Corporation $22 1 payment
  11. Other $40 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2022
  1. Food and Beverage $892 56 payments
Products named General payments · program years 2021–2022
  1. RYBELSUS $167 10 payments
  2. Ozempic $167 10 payments
  3. UBRELVY $106 6 payments
  4. SOLIQUA 100/33 $87 6 payments
  5. Kerendia $87 5 payments
  6. JARDIANCE $82 5 payments
  7. BREZTRI $74 5 payments
  8. NEXLETOL $57 4 payments
  9. ENTRESTO $46 3 payments
  10. SYNJARDY $45 3 payments
  11. Other $312 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

233

Median for Nurse Practitioner: 389

Drug cost

$1,901

Median for Nurse Practitioner: $21,885

Branded share of claims

7.7%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Albuterol Sulfate Hfa Albuterol Sulfate Brand 18 $567
Potassium Chloride Generic 11 $299
Atorvastatin Calcium Generic 34 $254
Gabapentin Generic 12 $123
Levothyroxine Sodium Generic 14 $96
Omeprazole Generic 16 $91
Pravastatin Sodium Generic 11 $86
Pantoprazole Sodium Generic 11 $85
Losartan Potassium Generic 15 $76
Amlodipine Besylate Generic 28 $67

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 3 billing codes

Paid by Medicare

$54,464

Medicare's payments for the services billed

Medicare patients

143

Average age 76

Services billed

1,173

88 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 45%
Ischemic heart disease 38%
Chronic kidney disease 36%
Depression 31%
Heart failure 24%
Cancer 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record